Sandrine Geffroy

2.1k total citations
32 papers, 949 citations indexed

About

Sandrine Geffroy is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Sandrine Geffroy has authored 32 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 13 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Sandrine Geffroy's work include Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer Genomics and Diagnostics (6 papers). Sandrine Geffroy is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer Genomics and Diagnostics (6 papers). Sandrine Geffroy collaborates with scholars based in France, United States and Belgium. Sandrine Geffroy's co-authors include Claude Preudhomme, Aline Renneville, Nicolas Boissel, Hervé Dombret, Olivier Nibourel, Bruno Quesnel, N Philippe, Martin Figeac, Catherine Roche‐Lestienne and Christophe Roumier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Sandrine Geffroy

29 papers receiving 938 citations

Peers

Sandrine Geffroy
L-Y Shih Taiwan
Salil Goorha United States
Sandrine Geffroy
Citations per year, relative to Sandrine Geffroy Sandrine Geffroy (= 1×) peers Mauro Nanni

Countries citing papers authored by Sandrine Geffroy

Since Specialization
Citations

This map shows the geographic impact of Sandrine Geffroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Geffroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Geffroy more than expected).

Fields of papers citing papers by Sandrine Geffroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Geffroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Geffroy. The network helps show where Sandrine Geffroy may publish in the future.

Co-authorship network of co-authors of Sandrine Geffroy

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Geffroy. A scholar is included among the top collaborators of Sandrine Geffroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Geffroy. Sandrine Geffroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebon, Delphine, Véronique Harrivel, Alice Marceau‐Renaut, et al.. (2025). Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia. British Journal of Haematology. 207(5). 1953–1961. 1 indexed citations
2.
Jeanpierre, Emmanuelle, Pierre Boisseau, Catherine Ternisien, et al.. (2023). PB0818 Impact of ABO Blood Group Genotype on VWF Level in Carriers of Type 3 von Willebrand Disease from the French von Willebrand Disease Reference Center. Research and Practice in Thrombosis and Haemostasis. 7. 101536–101536.
3.
Duployez, Nicolas, Martin Figeac, Sandrine Geffroy, et al.. (2022). Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r. BMC Bioinformatics. 23(1). 448–448.
4.
Duployez, Nicolas, Christophe Roumier, Nicolas Boissel, et al.. (2018). SNP-array lesions in core binding factor acute myeloid leukemia. Oncotarget. 9(5). 6478–6489. 10 indexed citations
5.
Boissel, Nicolas, Nathalie Hélevaut, Jordan Madic, et al.. (2018). Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group. Haematologica. 103(5). 822–829. 34 indexed citations
6.
Poulain, Stéphanie, Christophe Roumier, Elisabeth Bertrand, et al.. (2017). TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia. Clinical Cancer Research. 23(20). 6325–6335. 62 indexed citations
7.
Duployez, Nicolas, Alice Marceau‐Renaut, Nicolas Boissel, et al.. (2016). Comprehensive mutational profiling of core binding factor acute myeloid leukemia. Blood. 127(20). 2451–2459. 150 indexed citations
8.
Poulain, Stéphanie, Christophe Roumier, Martin Figeac, et al.. (2015). Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia. Clinical Cancer Research. 22(6). 1480–1488. 82 indexed citations
9.
Poulain, Stéphanie, Christophe Roumier, Martin Figeac, et al.. (2014). Genomic Landscape of CXCR4 Mutations in Waldenstrom's Macroglobulinemia. Blood. 124(21). 1627–1627. 1 indexed citations
10.
Poulain, Stéphanie, Eileen M. Boyle, Christophe Roumier, et al.. (2014). MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome. British Journal of Haematology. 167(4). 506–513. 48 indexed citations
11.
Gay, Julie, Céline Berthon, Lionel Adès, et al.. (2014). Molecular Prognostic Factors in Acute Myeloid Leukemia (AML) Patients Receiving First Line Therapy with Azacytidine (AZA). Blood. 124(21). 482–482. 2 indexed citations
12.
Micol, Jean‐Baptiste, Nicolas Duployez, Nicolas Boissel, et al.. (2014). Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations. Blood. 124(9). 1445–1449. 69 indexed citations
13.
Marceau‐Renaut, Alice, Aline Renneville, Olivier Nibourel, et al.. (2013). New-generation sequencing (NGS) in hematologic oncology laboratories. Hématologie. 19(2). 112–122. 2 indexed citations
14.
Nibourel, Olivier, Olivier Kosmider, Meyling Cheok, et al.. (2009). Association of TET2 Alterations with NPM1 Mutations and Prognostic Value in De Novo Acute Myeloid Leukemia (AML).. Blood. 114(22). 163–163. 6 indexed citations
16.
Andrieux, Joris, Catherine Roche‐Lestienne, Sandrine Geffroy, et al.. (2007). Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. Cancer Genetics and Cytogenetics. 178(1). 11–16. 8 indexed citations
17.
Andrieux, Joris, Sandrine Geffroy, Chrystèle Bilhou‐Nabera, et al.. (2005). Cryptic 6p21.3 duplications and triplication involving HMGA1 partially masked by add 6p in four cases of myelodysplasia. Cancer Genetics and Cytogenetics. 164(1). 84–87. 8 indexed citations
18.
Nicodème, Frédéric, Sandrine Geffroy, Massimo Conti, et al.. (2005). Familial occurrence of thymoma and autoimmune diseases with the constitutional translocation t(14;20)(q24.1;p12.3). Genes Chromosomes and Cancer. 44(2). 154–160. 14 indexed citations
19.
Martin, Geneviève, Masami Nemoto, Laurent Gelman, et al.. (2000). The Human Fatty Acid Transport Protein-1 (SLC27A1; FATP-1) cDNA and Gene: Organization, Chromosomal Localization, and Expression. Genomics. 66(3). 296–304. 45 indexed citations
20.
Geffroy, Sandrine, et al.. (1995). Localization of the Human OB Gene (OBS) to Chromosome 7q32 by Fluorescence in Situ Hybridization. Genomics. 28(3). 603–604. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026